Medicine

Targeting macrophages: a novel treatment strategy in solid tumors | Journal of Translational Medicine

The most widely studied targeted therapies are the blocking of overexpressed genes, increased activation of tumor suppressor genes, targeting of tumor cell antigens, inducement of anti-tumor cell antigen activity, and inhibition or alteration of signals that control tumor cell growth and proliferation [100]. However, in recent years, an increasing number of studies have focused on …

Targeting macrophages: a novel treatment strategy in solid tumors | Journal of Translational Medicine Read More »

Insilico Medicine names preclinical candida

Insilico Medicine (“Insilico”), a clinical-stage, end-to-end, artificial intelligence (AI)-driven drug discovery company, today announced that the company’s drug discovery team has nominated a preclinical candidate targeting KAT6A for ER+/HER2- breast cancer therapies using its end-to-end Pharma.AI platform. The company has now nominated eight preclinical candidates for 2022. According to statistics published by the International Agency …

Insilico Medicine names preclinical candida Read More »